BDA
ABBV icon

Borer Denton & Associates’s AbbVie ABBV Stock Holding History

Borer Denton & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Buy
58,459
+1,415
+2% +$304K 4.83% 6
2026
Q1 		$12.4M Sell
57,044
-880
-2% -$195K 4.43% 6
2025
Q4 		$13.2M Sell
57,924
-305
-0.5% -$69.5K 4.46% 5
2025
Q3 		$13.5M Buy
58,229
+245
+0.4% +$49.9K 4.45% 7
2025
Q2 		$10.8M Sell
57,984
-25
-0% -$4.65K 3.74% 8
2025
Q1 		$12.2M Sell
58,009
-1,225
-2% -$238K 4.3% 7
2024
Q4 		$10.5M Buy
59,234
+920
+2% +$169K 3.66% 7
2024
Q3 		$11.5M Buy
58,314
+1,405
+2% +$262K 3.93% 7
2024
Q2 		$9.76M Sell
56,909
-1,800
-3% -$298K 3.54% 8
2024
Q1 		$10.7M Buy
58,709
+694
+1% +$120K 3.78% 8
2023
Q4 		$8.99M Hold
58,015
– – 3.44% 12
2023
Q3 		$8.65M Hold
58,015
– – 3.57% 12
2023
Q2 		$7.82M Hold
58,015
– – 3.08% 14
2023
Q1 		$9.25M Buy
58,015
+503
+0.9% +$76.9K 3.84% 11
2022
Q4 		$9.29M Buy
57,512
+362
+0.6% +$55.5K 4.12% 7
2022
Q3 		$7.67M Sell
57,150
-102
-0.2% -$14.6K 3.82% 9
2022
Q2 		$8.77M Sell
57,252
-100
-0.2% -$15.3K 4.23% 8
2022
Q1 		$9.3M Buy
+57,352
New +$8.33M 3.9% 8

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Borer Denton & Associates's ABBV Position: Q2 2026 in Review

Borer Denton & Associates increased its AbbVie (ABBV) stake by 2.5% in Q2 2026, buying an estimated $304K and bringing the position to 58,459 shares worth $14.7M. The position accounts for 4.83% of the portfolio, ranked #6.

Borer Denton & Associates first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Borer Denton & Associates held 58,459 shares of AbbVie worth $14.7M as of Q2 2026.
  • Borer Denton & Associates bought 1,415 AbbVie shares in Q2 2026, an estimated $304K.
  • AbbVie made up 4.83% of Borer Denton & Associates's portfolio in Q2 2026, its #6 holding.
  • Borer Denton & Associates first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Borer Denton & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.